Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: Results in 120 consecutive patients

Annals of Surgery

Volumn 224, Issue 3, 1996, Pages 288-296

  Sugarbaker, David J ^a   Garcia, Jose P ^a   Richards, William G ^a   Harpole Jr , David H ^a   Healy Baldini, Elizabeth ^a   DeCamp Jr , Malcolm M ^a   Mentzer, Steven J ^a   Liptay, Michael J ^a   Strauss, Gary M ^a   Swanson, Scott J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; FEMALE; HUMAN; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIMODALITY CANCER THERAPY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TREATMENT PLANNING;

COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLEURAL NEOPLASMS; PNEUMONECTOMY; PROGNOSIS; SURVIVAL RATE;

EID: 9544247724     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199609000-00005     Document Type: Conference Paper

References (40)

1. Connelly RR, Spirtas R, Myers MH, et al. Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst 1987; 78:1053-1060.
2. Enterline PE, Henderson VL. Geographic patterns of pleural mesothelioma deaths in the United States, 1968-81. J Natl Cancer Inst 1987; 79:31-37.
3. Walker AM, Loughlin JE, Freidlander ER, et al. Projections of asbestos-related disease 1980-2009. J Occup Med 1983; 25:409-425.
4. Antman KH, Pass HI, DeLaney T, et al. Benign and malignant mesothelioma. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 4th ed. Philadelphia: JB Lippincott Co; 1993; 1489-1508.
5. Antman K, Pass HI, Recht A. Benign and malignant mesothelioma. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 3rd ed. Philadelphia: JB Lippincott Co; 1989:1399-1414.
6. Chahinian AP, Ambinder RM, Mandel EM, Holland JF. Evalua- tion of 63 patients with diffuse malignant mesothelima. Proc Am Soc Clin Oncol 1980; 21:360 (abstract).
7. Law MR, Hudson ME, Turner-Warwick M. Malignant mesothelioma of the pleura: clinical aspects and symptomatic treatment. Eur J Respir Dis 1984; 65:162-168 (abstract).
8. Ruffie P, Feld R, Minkin S, et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 1989; 7:1157-1168 (abstract).
9. Antman K, Shemin R, Ryan L, et al. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol 1988; 6:147-153.
10. Sugarbaker DJ, Heher EC, Lee TH, et al. Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma. J Thorac Cardiovasc Surg 1991; 102:10-14 (discussion).
11. Antman KH, Blum RH, Greenberger JS, et al. Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med 1980; 68:356-362.
12. Alien KB, Faber LP, Warren WH. Malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy. Chest Surg Clin North Am 1994; 4:113-126.
13. Worn H. Moglichkeiten und ergebnisse der chirurgischen behandlung des malignen pleuramesotheliomas. Thoraxchir Vask Chir 1974; 22:391-393.
14. Rusch VW, Piantadosi S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma: A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg 1991; 102:1-9.
15. Sugarbaker DJ, Strauss GM, Lynch TJ, et al. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol 1993; 11:1172-1178.
16. Sugarbaker DJ, Jaklitsch MT, Soutier AD, et al. Multimodality therapy of malignant mesothelioma. In: Roth JA, Ruckdeschel JC, Weisenburger TH, eds. Thoracic Oncology. 2nd ed. Philadelphia: WB Saunders Co; 1996:538-555.
17. Falkson G, Alberts AS, Falkson HC. Malignant pleural mesothelioma treatment: the current state of the art. Cancer Treat Rev 1988; 15:231-242.
18. Gordon W Jr. Antman KH, Greenberger JS, et al. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys 1982; 8:19-25.
19. Eschwege F, Schlienger M. Radiotherapy of malignant pleural mesotheliomas: apropos of 14 cases irradiated at high doses. J Radiol Electrol Med Nucl 1973; 54:255-259.
20. Law MR, Gregor A, Hodson ME. et al. Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax 1984; 39:255-259.
21. Rusch VW. Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma. Chest 1993; 103(suppl):382S-384S.
22. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients. Thorax 1976; 31: 15-24.
23. Sugarbaker DJ, Mentzer SJ, Strauss G. Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma. Ann Thorac Surg 1992; 54:941-946.
24. Ginsberg RJ, Hill LD, Eagan RT, et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983; 86:654-658.
25. Kalbfleish JD. The Statistical Analysis of Failure Time Data. New York: John Wiley; 1980.
26. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972; 34:187-202.
27. Mychalsak BR, Nori D, Armstrong JG, et al. Results of treatment of malignant pleural mesothelioma with surgery, brachytherapy, and external beam irradiation. Endocurie Hypertherm Oncol 1989; 5:245.
28. McCormack PM, Nagasaki F, Hilaris BS, Martini N. Surgical treatment of pleural mesothelioma. J Thorac Cardiovasc Surg 1982; 84:834-842.
29. Rusch VW. Trials in malignant mesothelioma: LCSG 851 and 882. Chest 1994; 106:359S-362S.
30. Harvey VJ, Slevin ML, Ponder BA, et al. Chemotherapy of diffuse malignant mesothelioma: phase II trials of single agent 5-fluorouracil and adriamycin. Cancer 1984; 54:961-964.
31. Gerner RE, Moore GE. Chemotherapy of malignant mesothelioma. Oncology 1974; 30:152-155.
32. Daboys G, Delajartre M, Le Mevel B. Treatment of diffuse pleural malignant mesothelioma by cisdichlorodiamine platinum in nine patients. Cancer Chemother Pharmacol 1981; 5:209-210.
33. Kelsen D, Bajorin D, Mintzer D. Phase II trial of mitomycin C in malignant mesothelioma: Proc Am Soc Clin Oncol 1985; 4:146 (abstract).
34. Chahinian AP, Antman K, Goutsou M, et al. Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B. J Clin Oncol 1993; 11:1559-1565.
35. Faber LP, Bonomi PD. Combined preoperative chemoradiation therapy. Chest Surg Clin North Am 1991; 1:43-59.
36. Forastiere AA, Orringer MB, Perez-Tamayo C, et al. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol 1990; 8:119-127.
37. Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 1990; 323:940-945.
38. Rusch VW, Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 1996; 111:815-826.
39. Nauta RJ, Osteen RT, Antman KH, Ilstrup DM. Clinical staging and the tendency of malignant pleural mesotheliomas to remain localized. Ann Thorac Surg 1982; 34:66-70.
40. Patz EF Jr, Shaffer K, Piwnica-Worms DR, et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol 1992; 159:961-966.